Dermatosis solares idiopáticas
Palabras clave:
dermatosis solares, fotodermatosis, radiación ultravioletaResumen
Las dermatosis solares idiopáticas representan un grupo de enfermedades en las que un cromóforo endógeno es modificado por la acción de la radiación
ultravioleta y desencadena cuadros clínicos característicos.
La más común de estas entidades es la erupción polimorfa solar, que representa la tercera parte de todas las fotodermatosis.
Es importante el estudio de las dermatosis solares idiopáticas, ya que son entidades frecuentes, tienen un impacto negativo en la calidad de vida del paciente y muestran características similares a otras enfermedades cutáneas.
Un adecuado diagnóstico es crucial para determinar el abordaje terapéutico, aunque en algunas ocasiones puede haber resolución espontánea.
Biografía del autor/a
Giovana Fernanda Osorio Gómez, Universidad del Valle
R3 Dermatología de la Universidad del Valle
Referencias bibliográficas
1. González E, González S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol 1996; 35(6): 871-885. 38s.
https://doi.org/10.1016/S0190-9622(96)90108-5
2. Samson-Yashar S, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther 2003; 16: 1-7.
https://doi.org/10.1046/j.1529-8019.2003.01601.x
3. Kolgen W, Van Meurs M, Jongsma M, Van Weelden H, Bruijnzeel-Komen C, Knol E. Differential expresión of cytokines in UVB-exposed skin of patients with polymorphous light eruption. Arch Dermatol 2004; 140:295-302.
https://doi.org/10.1001/archderm.140.3.295
4. Dawe SA, Stephens A. Congenital erythropoietic porphyria: dilemmas in present day management. Clin & Exp Dermatol 2002; 27(8): 680-683.
https://doi.org/10.1046/j.1365-2230.2002.01166.x
5. Samson-Yashar S, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther 2003; 16: 1-7.
https://doi.org/10.1046/j.1529-8019.2003.01601.x
6. Boonstra HE, Van Weelden H, Toonstra J, Van Vloten WA. Polymorphous light eruption: A clinical follow-up study of 11 O patients. J Am Acad Dermatol 2000; 42: 199-207.
https://doi.org/10.1016/S0190-9622(00)90126-9
7. Millard TP, Hawk JL. Photosensitivity disorders: cause, effect and management. Am J Clin Dermatol 2002; 3: 239-246.
https://doi.org/10.2165/00128071-200203040-00002
8. Stratigos AJ, Antoniou C, Katsambas AD. Polymorphous light eruption. JEADV 2002; 16: 193- 206.
https://doi.org/10.1046/j.1468-3083.2002.00443.x
9. Hawk JL, Norris PG, Hónigsmann H. Abnormal responses to ultraviolet radiation: idiopathic, probably immunologic, and photoexacerbated. En: Fitzpatrick's dermatology in general medicine, 6th ed. New York: Me Graw-Hill 1999: 1283-1298.
10. Naleway A. Polymorphous light eruption. lnt J Dermatol 2002; 41: 377-83.
https://doi.org/10.1046/j.1365-4362.2002.01467.x
11. Tutrone WD, Thornton-Spann C, Scheinfeld N, Deleo VA. Polymorphic light eruption. Dermatol Ther 2003; 16: 28-39.
https://doi.org/10.1046/j.1529-8019.2003.01605.x
12. Stratigos AJ, Antoniou C, Papadakis P, Papapostolou A, Sabatziotis D, Tranaka K, Tsara K, Katsambas A. Juvenile spring eruption: Clinicopathologic features phototesting results in 4 cases. J Am Acad Dermatol 2004; 50: S57-60.
https://doi.org/10.1016/S0190-9622(03)02469-1
13. Millard TP, Bataille V, Sneider H, Spector TD, McGregor JM. The heritability of polymorphic light eruption. J lnvest Dermatol 2000; 115: 467-4 70.
https://doi.org/10.1046/j.1523-1747.2000.00079.x
14. Holzle E, Plewing, G, von Kries R, et al. Polymorphous light eruption. J lnvest Dermatol 1987; 88(suppl):32s-38s.
https://doi.org/10.1038/jid.1987.7
15. McGregor JM, Grabczynska S, Vaughan R, Hawk J, Lewis C. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo. J lnvest Dermatol 2000; 115: 4 71-6.
https://doi.org/10.1046/j.1523-1747.2000.00080.x
16. Schornagel IJ, Sigurdsson V, Nijhuis E, Bruijnzeel-Ko- men C, Knol E. Decreased neutrophil skin infiltration alter UVB exposure in patients with polymorphous light eruption. J lnvest Dermatol 2004; 123: 202-206.
https://doi.org/10.1111/j.0022-202X.2004.22734.x
17. Farr PM, Diffey BL. Effect of indomethacin on UVB and UVA-induced erythema in polymorphic light eruption. J Am Acad Dermatol 1989; 21: 230-236.
https://doi.org/10.1016/S0190-9622(89)70166-3
18. Ferguson J. Diagnosis and treatment of the common idiopathic photodermatoses. Australas J Dermatol 2003; 44: 90-96.
https://doi.org/10.1046/j.1440-0960.2003.00652.x
19. Przybilla 8, Galosi A, Heppeler M, Rizicka T, Ring J. Polymorphous light eruption: Eliciting and inhibiting wavelengths. Acta Derm Veneorol 1988; 68(2):173-6.
20. Van de Pas CB, Hawk JL, Young AR, Walker SL. An optima! method for experimental provocation of po- lymorphous light eruption. Arch Dermatol 2004; 140: 286- 92.
https://doi.org/10.1001/archderm.140.3.286
21. Murphy GM, Hawk JLM. The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption. Br J Dermatol 1991; 125: 448-51.
https://doi.org/10.1111/j.1365-2133.1991.tb14770.x
22. Millard TP, Lewis CM, Khamashta MA, Hughes GR, Hawk JL, Mcgregor JM. Familia! clustering of po- lymorphous light eruption in relatives of patients with lupus erythematosus: evidence of a shared pathoge- nesis: Br J Dermatol 2001; 144: 334-8.
https://doi.org/10.1046/j.1365-2133.2001.03897.x
23. Hasan T, Ranki A, cansen CT, Karvonen J. Disease as- sociations in polymorphic light eruption. Arch Dermatol 1998; 134: 1081-85.
https://doi.org/10.1001/archderm.134.9.1081
24. Millard T, Kondeatis T, Cox A, Wilson AG, Grabczynska S, Carey B, et al. A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol 2001; 145: 229-36.
https://doi.org/10.1046/j.1365-2133.2001.04339.x
25. Wiseman M, Orr P, MacDonald S, Schroeder M, Toole J. Actinic prurigo: clinical features and HLA associations in Canadian lnuit population. J Am Acad Dermatol 2001; 44: 952-6.
https://doi.org/10.1067/mjd.2001.112579
26. Hojyo-Tomoka MT, Vega-Memije ME, Cortes-Franco R, Domínguez-Soto L. Diagnosis and treatment of actinic prurigo. Dermatol Ther 2003; 16: 40-4.
https://doi.org/10.1046/j.1529-8019.2003.01606.x
27. Durán MM, Berna! JE, Ordoñez CP. Actinic prurigo at sea level in Colombia. lnt J Dermatol 1989; 28: 228-9.
https://doi.org/10.1111/j.1365-4362.1989.tb04808.x
28. Lane PR, Hogan DJ, Marte! MJ, Reeder B, lrvine J. Actinic prurigo: clinical features and prognosis: J Am Acad Dermatol 1992; 26: 683-92.
https://doi.org/10.1016/0190-9622(92)70093-U
29. Crouch R, Foley P, Baker C. Actinic prurigo: A retros-pective analysis of 21 cases referred to an Australian photobiology clinic. Australasian J Dermatol 2002; 43: 128-32.
https://doi.org/10.1046/j.1440-0960.2002.00574.x
30. Grabczynska S, McGregor J, Kondeatis E, Vaughan R, Hawk J. Actinic prurigo and polymorphic light eruption: common pathogenesis and the importance of HLA-DR4/DRB1 *0407. Br J Dermatol 1999; 140: 232-6.
https://doi.org/10.1046/j.1365-2133.1999.02654.x
31. Umaña A, Gómez A, Durán M, Porras L. Lymphocyte subtypes and adhesion molecules in actinic prurigo: observations with cyclosporine A. lnt J Dermatol 2002; 41: 139-45.
https://doi.org/10.1046/j.1365-4362.2002.01419.x
32. Arrese J, Domínguez-Soto L, Hojyo-Tomoka M, Vega- Memije E, Cortes-Franco R, Guevara E, Piérard G. Effectors of inflamation in actinic prurigo. J Am Acad Dermatol 2001; 44: 957-61.
https://doi.org/10.1067/mjd.2001.113477
33. Magaña M, Mendez Y, Rodríguez A, Mascota M. The conjunctivitis of solar (actinic) prurigo. Ped Dermatol 2000; 17: 432-5
https://doi.org/10.1046/j.1525-1470.2000.01818.x
34. Duran MM, Ordoñez CP. Treatment of actinic prurigo in Chimila lndians. lnt J Dermatol 1995; 35: 413-6.
https://doi.org/10.1111/j.1365-4362.1996.tb03023.x
35. Dawe R, Ferguson J. Diagnosis and treatment of chro- nic actinic dermatitis. Dermatol Ther 2003; 16: 45-51.
https://doi.org/10.1046/j.1529-8019.2003.01607.x
36. Lim HW, Cohen D, Soler NA. Chronic actinic dermatitis: Results of patch and photopatch tests with Compo-sitae, fragantes, and pesticidas. J Am Acad Dermatol 1998; 38: 108-11.
https://doi.org/10.1016/S0190-9622(98)70549-3
37. Lim H, Morrison WL, Kamide R, Buchness MR, Harris R, Soter NA. Chronic actinic dermatitis: An analysis of 51 patients evaluated in the United States and Japan. Arch Dermatol Res 1994; 130: 1284-9.
https://doi.org/10.1001/archderm.1994.01690100068011
38. Sugita K, Shimauchi T, Tokura Y. Chronic actinic derma- titis associated with adult T-cell leucemia. J Am Acad Dermatol 2005; 52: s38-40.
https://doi.org/10.1016/j.jaad.2004.06.044
39. Bakels V, van Oostveen JW, Preesman AH, Meijer CJ, Willemze R. Differentiation between actinic reticuloid and cutaneous T lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping. J Clin Pathol 1998; 51: 154-8.
https://doi.org/10.1136/jcp.51.2.154
40. Bisland D, Crombie IK, Ferguson J. The photosensitivity dermatitis and actinic reticuloid síndrome: no associa- tion with lymphoreticular malignancy. Br J Dermatol 1994; 131: 209-14.
https://doi.org/10.1111/j.1365-2133.1994.tb08493.x
41. De Almeida HL. Successsfull treatment of chronic actinic dermatitis with topical pimecrolimus. lnt J Der-matol 2005; 44: 343.
https://doi.org/10.1111/j.1365-4632.2005.02352.x
42. Uetsu N; Okamoto H, Fujiii K, Doi R, Horio T. Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol 2002; 47: 881-4.
https://doi.org/10.1067/mjd.2002.124703
43. Leigh IM, Hawk JL. Treatment of chronic actinic der- matitis with azathioprine. Br J Dermatol 1984; 110: 691-5.
https://doi.org/10.1111/j.1365-2133.1984.tb04706.x
44. Thomson MA, Stewart DG, Lewis HM. Chronic actinic dermatitis treated with mycophenolate mofetil. Br J Dermatol 2005; 152: 784-6.
https://doi.org/10.1111/j.1365-2133.2005.06445.x
45. Nousari HC, Anhalt GJ, Morrison WL. Morrison WL. Mycophenolate in psoralen-UVA desensibilization therapy for chronic actinic dermatitis. Arch Dermatol 1999: 135: 1128-29.
https://doi.org/10.1001/archderm.135.9.1128
46. Eguino P, Gardeazabal J, Díaz-Pérez JL. Urticaria solar. Piel 2003; 18(9): 481-7.
https://doi.org/10.1016/S0213-9251(03)72762-2
47. Roelandts R. Diagnosis and treatment of solar urticaria. Dermatol Ther 2003; 16: 52-6.
https://doi.org/10.1046/j.1529-8019.2003.01608.x
48. Beattie P, Dawe R, lbbotson S, Ferguson J. Characte- ristics and prognosis of idiopathic solar urticaria. Arch Dermatol 2003; 139: 1149-54.
https://doi.org/10.1001/archderm.139.9.1149
49. Leenutaphong V, Hólzle E, Plewig G. Pathogenesis and classification of solar urticaria: new concept. J Am Acad Dermatol 1989; 21: 237-40.
https://doi.org/10.1016/S0190-9622(89)70167-5
50. Beattie P, Dawe R, lbbotson S, Ferguson J. Co-exis-tence of chronic actinic dermatitis and solar urticaria in three patients. Br J Dermatol 2004; 150: 506-8.
51. Leenutaphong V, Von Kries R, Hólzle E, Plewing G. Solar urticaria induced by visible light and inhibited by UVA. Photodermatology 1988; 5: 170-17 4.
52. Horio T, Fujigaki K. Augmentation spectrum in solar urticaria. J Am Acad Dermatol 1988; 18: 1189-93.
https://doi.org/10.1016/S0190-9622(88)70122-X
53. Gupta G. Man 1, Kemmett D. Hydroa vacciniforme: A clinical follow-up study of 17 cases. J Am Acad Der-matol 2000; 42: 208-13.
https://doi.org/10.1016/S0190-9622(00)90127-0
54. Wong SN, Tan SH, Khoo SW. Late-onset hydroa vaccinifor-me: two case reports. Br J Dermatol 2001; 144: 874-7.
https://doi.org/10.1046/j.1365-2133.2001.04149.x
55. Gupta G, Mohamed M, Kemmett D. Familia! hydroa vacciniforma. Br J Dermatol 1999; 140: 124-6.
https://doi.org/10.1046/j.1365-2133.1999.02620.x
56. Kim WS, Veo UC, Chun HS, Lee ES. A case of hydroa vacciniforme with unusual ear mutilation. Clin Exp Dermatol 1998; 23: 70-2.
https://doi.org/10.1046/j.1365-2230.1998.00298.x
57. lwatsuki K, Takata M, lguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y et al. The association of latent Epstein Barr virus infection with hydroa vacciniforma. Br J Dermatol 1999; 140: 715-21.
https://doi.org/10.1046/j.1365-2133.1999.02777.x
58. Rhodes LE, White SI. Dietary fish oil as a photoprotective agente in hydroa vacciniforme: Br J Dermatol 1998; 138: 173-8.
https://doi.org/10.1046/j.1365-2133.1998.02047.x
https://doi.org/10.1016/S0190-9622(96)90108-5
2. Samson-Yashar S, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther 2003; 16: 1-7.
https://doi.org/10.1046/j.1529-8019.2003.01601.x
3. Kolgen W, Van Meurs M, Jongsma M, Van Weelden H, Bruijnzeel-Komen C, Knol E. Differential expresión of cytokines in UVB-exposed skin of patients with polymorphous light eruption. Arch Dermatol 2004; 140:295-302.
https://doi.org/10.1001/archderm.140.3.295
4. Dawe SA, Stephens A. Congenital erythropoietic porphyria: dilemmas in present day management. Clin & Exp Dermatol 2002; 27(8): 680-683.
https://doi.org/10.1046/j.1365-2230.2002.01166.x
5. Samson-Yashar S, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther 2003; 16: 1-7.
https://doi.org/10.1046/j.1529-8019.2003.01601.x
6. Boonstra HE, Van Weelden H, Toonstra J, Van Vloten WA. Polymorphous light eruption: A clinical follow-up study of 11 O patients. J Am Acad Dermatol 2000; 42: 199-207.
https://doi.org/10.1016/S0190-9622(00)90126-9
7. Millard TP, Hawk JL. Photosensitivity disorders: cause, effect and management. Am J Clin Dermatol 2002; 3: 239-246.
https://doi.org/10.2165/00128071-200203040-00002
8. Stratigos AJ, Antoniou C, Katsambas AD. Polymorphous light eruption. JEADV 2002; 16: 193- 206.
https://doi.org/10.1046/j.1468-3083.2002.00443.x
9. Hawk JL, Norris PG, Hónigsmann H. Abnormal responses to ultraviolet radiation: idiopathic, probably immunologic, and photoexacerbated. En: Fitzpatrick's dermatology in general medicine, 6th ed. New York: Me Graw-Hill 1999: 1283-1298.
10. Naleway A. Polymorphous light eruption. lnt J Dermatol 2002; 41: 377-83.
https://doi.org/10.1046/j.1365-4362.2002.01467.x
11. Tutrone WD, Thornton-Spann C, Scheinfeld N, Deleo VA. Polymorphic light eruption. Dermatol Ther 2003; 16: 28-39.
https://doi.org/10.1046/j.1529-8019.2003.01605.x
12. Stratigos AJ, Antoniou C, Papadakis P, Papapostolou A, Sabatziotis D, Tranaka K, Tsara K, Katsambas A. Juvenile spring eruption: Clinicopathologic features phototesting results in 4 cases. J Am Acad Dermatol 2004; 50: S57-60.
https://doi.org/10.1016/S0190-9622(03)02469-1
13. Millard TP, Bataille V, Sneider H, Spector TD, McGregor JM. The heritability of polymorphic light eruption. J lnvest Dermatol 2000; 115: 467-4 70.
https://doi.org/10.1046/j.1523-1747.2000.00079.x
14. Holzle E, Plewing, G, von Kries R, et al. Polymorphous light eruption. J lnvest Dermatol 1987; 88(suppl):32s-38s.
https://doi.org/10.1038/jid.1987.7
15. McGregor JM, Grabczynska S, Vaughan R, Hawk J, Lewis C. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo. J lnvest Dermatol 2000; 115: 4 71-6.
https://doi.org/10.1046/j.1523-1747.2000.00080.x
16. Schornagel IJ, Sigurdsson V, Nijhuis E, Bruijnzeel-Ko- men C, Knol E. Decreased neutrophil skin infiltration alter UVB exposure in patients with polymorphous light eruption. J lnvest Dermatol 2004; 123: 202-206.
https://doi.org/10.1111/j.0022-202X.2004.22734.x
17. Farr PM, Diffey BL. Effect of indomethacin on UVB and UVA-induced erythema in polymorphic light eruption. J Am Acad Dermatol 1989; 21: 230-236.
https://doi.org/10.1016/S0190-9622(89)70166-3
18. Ferguson J. Diagnosis and treatment of the common idiopathic photodermatoses. Australas J Dermatol 2003; 44: 90-96.
https://doi.org/10.1046/j.1440-0960.2003.00652.x
19. Przybilla 8, Galosi A, Heppeler M, Rizicka T, Ring J. Polymorphous light eruption: Eliciting and inhibiting wavelengths. Acta Derm Veneorol 1988; 68(2):173-6.
20. Van de Pas CB, Hawk JL, Young AR, Walker SL. An optima! method for experimental provocation of po- lymorphous light eruption. Arch Dermatol 2004; 140: 286- 92.
https://doi.org/10.1001/archderm.140.3.286
21. Murphy GM, Hawk JLM. The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption. Br J Dermatol 1991; 125: 448-51.
https://doi.org/10.1111/j.1365-2133.1991.tb14770.x
22. Millard TP, Lewis CM, Khamashta MA, Hughes GR, Hawk JL, Mcgregor JM. Familia! clustering of po- lymorphous light eruption in relatives of patients with lupus erythematosus: evidence of a shared pathoge- nesis: Br J Dermatol 2001; 144: 334-8.
https://doi.org/10.1046/j.1365-2133.2001.03897.x
23. Hasan T, Ranki A, cansen CT, Karvonen J. Disease as- sociations in polymorphic light eruption. Arch Dermatol 1998; 134: 1081-85.
https://doi.org/10.1001/archderm.134.9.1081
24. Millard T, Kondeatis T, Cox A, Wilson AG, Grabczynska S, Carey B, et al. A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol 2001; 145: 229-36.
https://doi.org/10.1046/j.1365-2133.2001.04339.x
25. Wiseman M, Orr P, MacDonald S, Schroeder M, Toole J. Actinic prurigo: clinical features and HLA associations in Canadian lnuit population. J Am Acad Dermatol 2001; 44: 952-6.
https://doi.org/10.1067/mjd.2001.112579
26. Hojyo-Tomoka MT, Vega-Memije ME, Cortes-Franco R, Domínguez-Soto L. Diagnosis and treatment of actinic prurigo. Dermatol Ther 2003; 16: 40-4.
https://doi.org/10.1046/j.1529-8019.2003.01606.x
27. Durán MM, Berna! JE, Ordoñez CP. Actinic prurigo at sea level in Colombia. lnt J Dermatol 1989; 28: 228-9.
https://doi.org/10.1111/j.1365-4362.1989.tb04808.x
28. Lane PR, Hogan DJ, Marte! MJ, Reeder B, lrvine J. Actinic prurigo: clinical features and prognosis: J Am Acad Dermatol 1992; 26: 683-92.
https://doi.org/10.1016/0190-9622(92)70093-U
29. Crouch R, Foley P, Baker C. Actinic prurigo: A retros-pective analysis of 21 cases referred to an Australian photobiology clinic. Australasian J Dermatol 2002; 43: 128-32.
https://doi.org/10.1046/j.1440-0960.2002.00574.x
30. Grabczynska S, McGregor J, Kondeatis E, Vaughan R, Hawk J. Actinic prurigo and polymorphic light eruption: common pathogenesis and the importance of HLA-DR4/DRB1 *0407. Br J Dermatol 1999; 140: 232-6.
https://doi.org/10.1046/j.1365-2133.1999.02654.x
31. Umaña A, Gómez A, Durán M, Porras L. Lymphocyte subtypes and adhesion molecules in actinic prurigo: observations with cyclosporine A. lnt J Dermatol 2002; 41: 139-45.
https://doi.org/10.1046/j.1365-4362.2002.01419.x
32. Arrese J, Domínguez-Soto L, Hojyo-Tomoka M, Vega- Memije E, Cortes-Franco R, Guevara E, Piérard G. Effectors of inflamation in actinic prurigo. J Am Acad Dermatol 2001; 44: 957-61.
https://doi.org/10.1067/mjd.2001.113477
33. Magaña M, Mendez Y, Rodríguez A, Mascota M. The conjunctivitis of solar (actinic) prurigo. Ped Dermatol 2000; 17: 432-5
https://doi.org/10.1046/j.1525-1470.2000.01818.x
34. Duran MM, Ordoñez CP. Treatment of actinic prurigo in Chimila lndians. lnt J Dermatol 1995; 35: 413-6.
https://doi.org/10.1111/j.1365-4362.1996.tb03023.x
35. Dawe R, Ferguson J. Diagnosis and treatment of chro- nic actinic dermatitis. Dermatol Ther 2003; 16: 45-51.
https://doi.org/10.1046/j.1529-8019.2003.01607.x
36. Lim HW, Cohen D, Soler NA. Chronic actinic dermatitis: Results of patch and photopatch tests with Compo-sitae, fragantes, and pesticidas. J Am Acad Dermatol 1998; 38: 108-11.
https://doi.org/10.1016/S0190-9622(98)70549-3
37. Lim H, Morrison WL, Kamide R, Buchness MR, Harris R, Soter NA. Chronic actinic dermatitis: An analysis of 51 patients evaluated in the United States and Japan. Arch Dermatol Res 1994; 130: 1284-9.
https://doi.org/10.1001/archderm.1994.01690100068011
38. Sugita K, Shimauchi T, Tokura Y. Chronic actinic derma- titis associated with adult T-cell leucemia. J Am Acad Dermatol 2005; 52: s38-40.
https://doi.org/10.1016/j.jaad.2004.06.044
39. Bakels V, van Oostveen JW, Preesman AH, Meijer CJ, Willemze R. Differentiation between actinic reticuloid and cutaneous T lymphoma by T cell receptor gamma gene rearrangement analysis and immunophenotyping. J Clin Pathol 1998; 51: 154-8.
https://doi.org/10.1136/jcp.51.2.154
40. Bisland D, Crombie IK, Ferguson J. The photosensitivity dermatitis and actinic reticuloid síndrome: no associa- tion with lymphoreticular malignancy. Br J Dermatol 1994; 131: 209-14.
https://doi.org/10.1111/j.1365-2133.1994.tb08493.x
41. De Almeida HL. Successsfull treatment of chronic actinic dermatitis with topical pimecrolimus. lnt J Der-matol 2005; 44: 343.
https://doi.org/10.1111/j.1365-4632.2005.02352.x
42. Uetsu N; Okamoto H, Fujiii K, Doi R, Horio T. Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol 2002; 47: 881-4.
https://doi.org/10.1067/mjd.2002.124703
43. Leigh IM, Hawk JL. Treatment of chronic actinic der- matitis with azathioprine. Br J Dermatol 1984; 110: 691-5.
https://doi.org/10.1111/j.1365-2133.1984.tb04706.x
44. Thomson MA, Stewart DG, Lewis HM. Chronic actinic dermatitis treated with mycophenolate mofetil. Br J Dermatol 2005; 152: 784-6.
https://doi.org/10.1111/j.1365-2133.2005.06445.x
45. Nousari HC, Anhalt GJ, Morrison WL. Morrison WL. Mycophenolate in psoralen-UVA desensibilization therapy for chronic actinic dermatitis. Arch Dermatol 1999: 135: 1128-29.
https://doi.org/10.1001/archderm.135.9.1128
46. Eguino P, Gardeazabal J, Díaz-Pérez JL. Urticaria solar. Piel 2003; 18(9): 481-7.
https://doi.org/10.1016/S0213-9251(03)72762-2
47. Roelandts R. Diagnosis and treatment of solar urticaria. Dermatol Ther 2003; 16: 52-6.
https://doi.org/10.1046/j.1529-8019.2003.01608.x
48. Beattie P, Dawe R, lbbotson S, Ferguson J. Characte- ristics and prognosis of idiopathic solar urticaria. Arch Dermatol 2003; 139: 1149-54.
https://doi.org/10.1001/archderm.139.9.1149
49. Leenutaphong V, Hólzle E, Plewig G. Pathogenesis and classification of solar urticaria: new concept. J Am Acad Dermatol 1989; 21: 237-40.
https://doi.org/10.1016/S0190-9622(89)70167-5
50. Beattie P, Dawe R, lbbotson S, Ferguson J. Co-exis-tence of chronic actinic dermatitis and solar urticaria in three patients. Br J Dermatol 2004; 150: 506-8.
51. Leenutaphong V, Von Kries R, Hólzle E, Plewing G. Solar urticaria induced by visible light and inhibited by UVA. Photodermatology 1988; 5: 170-17 4.
52. Horio T, Fujigaki K. Augmentation spectrum in solar urticaria. J Am Acad Dermatol 1988; 18: 1189-93.
https://doi.org/10.1016/S0190-9622(88)70122-X
53. Gupta G. Man 1, Kemmett D. Hydroa vacciniforme: A clinical follow-up study of 17 cases. J Am Acad Der-matol 2000; 42: 208-13.
https://doi.org/10.1016/S0190-9622(00)90127-0
54. Wong SN, Tan SH, Khoo SW. Late-onset hydroa vaccinifor-me: two case reports. Br J Dermatol 2001; 144: 874-7.
https://doi.org/10.1046/j.1365-2133.2001.04149.x
55. Gupta G, Mohamed M, Kemmett D. Familia! hydroa vacciniforma. Br J Dermatol 1999; 140: 124-6.
https://doi.org/10.1046/j.1365-2133.1999.02620.x
56. Kim WS, Veo UC, Chun HS, Lee ES. A case of hydroa vacciniforme with unusual ear mutilation. Clin Exp Dermatol 1998; 23: 70-2.
https://doi.org/10.1046/j.1365-2230.1998.00298.x
57. lwatsuki K, Takata M, lguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y et al. The association of latent Epstein Barr virus infection with hydroa vacciniforma. Br J Dermatol 1999; 140: 715-21.
https://doi.org/10.1046/j.1365-2133.1999.02777.x
58. Rhodes LE, White SI. Dietary fish oil as a photoprotective agente in hydroa vacciniforme: Br J Dermatol 1998; 138: 173-8.
https://doi.org/10.1046/j.1365-2133.1998.02047.x
Cómo citar
1.
Osorio Gómez GF. Dermatosis solares idiopáticas. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de octubre de 2006 [citado 19 de abril de 2024];14(3):241-57. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/484
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2006-10-01
Cómo citar
1.
Osorio Gómez GF. Dermatosis solares idiopáticas. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de octubre de 2006 [citado 19 de abril de 2024];14(3):241-57. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/484
Número
Sección
Sin sección en el original
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
